Clinical Trials in Arizona

Showing 741-760 of 8,032 trials

Growth Hormone for the Treatment of Gastroparesis

NCT06803589

The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

Gastroparesis

Mayo Clinic10 participantsStarted Oct 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States

RECRUITINGNA31 miles

Shared Decision Making to Improve Goals of Care in the ED

NCT03833622

This project will develop and refine a shared decision making (SDM) intervention (decision aid tool) to improve and normalize high quality end of life discussions in the Emergency Department (ED) setting.

Goals

Mayo Clinic230 participantsStarted Mar 2018

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

RECRUITINGNA31 miles

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

NCT06321575

The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.

Peripheral Arterial Disease

Avantec Vascular159 participantsStarted Jun 2024

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Merced, California, United States +17 more locations

Growth Hormone for the Treatment of Gastroparesis

Shared Decision Making to Improve Goals of Care in the ED

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Find Trials by Condition in Arizona

FX Shoulder Prospective Clinical Study

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

A Study of Barzolvolimab in Patients With Atopic Dermatitis

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Galleri® in the Medicare Population.

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

FdCyd and THU for Advanced Solid Tumors

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies